Summary & Overview
CPT 83033: Hemoglobin F Detection in Whole Blood
CPT code 83033 denotes a laboratory assay for the detection of hemoglobin F (fetal hemoglobin) in whole blood. Clinically, this test is important for neonatal evaluation and for diagnosing or monitoring hemoglobinopathies and certain hematologic conditions in older patients. Nationally, the test supports newborn screening and targeted diagnostic workflows in hospitals and clinical laboratories.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical sites of service, and the kinds of billing and coverage considerations that commonly arise with hemoglobin F testing. The publication also outlines benchmarking and payer coverage perspectives where available, summarizes relevant clinical indications, and highlights areas where policy updates or payer-specific rules may affect claims processing.
This summary is intended for a national audience of hospital administrators, laboratory managers, and revenue cycle professionals seeking a clear, practical reference to CPT code 83033, its clinical purpose, and what to expect in payer interactions and billing practice. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 83033 tests for the presence of hemoglobin F (fetal hemoglobin), typically performed on a whole blood specimen. The test detects and quantifies hemoglobin F, which is normally present at very low levels in older infants and adults but constitutes the majority of hemoglobin in newborn infants.
Service Type: Laboratory test — hematology/hemoglobin analysis
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A newborn infant in the well-baby nursery or neonatal intensive care unit undergoes routine newborn screening and evaluation for hemoglobinopathies. A clinician orders a hemoglobin F quantitation to assess the percentage of fetal hemoglobin when there is concern for hemoglobinopathies (such as beta thalassemia), prematurity, or when interpreting abnormal newborn screening results. A phlebotomist obtains a whole blood sample (often via heel stick or venipuncture) which is sent to the clinical laboratory. The laboratory analyst performs assay 83033 to detect and quantify hemoglobin F. Results are reviewed by a pathologist or clinical laboratory scientist and released to the ordering provider, who integrates the value with newborn screening, clinical exam, and family history to guide further testing or referral to pediatric hematology.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional interpretation component separate from the technical lab processing if billing separates components. |
TC | Technical component |